Pune, India -- (SBWIRE) -- 07/03/2018 -- Monoclonal Antibody Custom Service Market – Overview
The use of monoclonal antibody custom service has grown at an increased pace because of increased consumption demand. Market concentrated reports associated with the healthcare industry amid others recently have been made available by Market Research Future which issues reports on this industry. The market for monoclonal antibody custom service market globally is anticipated to earn revenues worth USD 1,461.93 million by 2023 while expanding at a CAGR of 10.84% in the forecast period.
The inclusive services for expression, antibody cloning, engineering, and purification are the main factors that are contributing to the progress of the market in the forecast period. Amplified focus on research & development related to this market is powering the growth of the market at an enhanced pace in the forecast period. The market also has gained a significant push due to growth in the number of cases for chronic diseases that are being detected around the world.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515
Industry Segments
The monoclonal antibody custom service market globally is segmented on the basis of application, type, and end-users. The type segment of the market is segmented into rabbit custom monoclonal antibody, rat custom monoclonal antibody, and others. The rabbit monoclonal antibody market is expected to grow at the fastest CAGR of 11.48% during the forecast period. The segmentation based on application consists of therapeutic application, diagnostic application, and protein purification. The diagnostic application is additionally sub-segmented into diagnostic imaging and biochemical analysis. The biochemical analysis is furthermore segmented into cancer, hormonal disorder, pregnancy, and infectious diseases. The diagnostic imaging segment is moreover segmented into cancer, cardiovascular diseases and bacterial infections. The therapeutic application is additionally segmented into MAb as targeting agents and MAb as therapeutic agents. The segment of end users in the market is segmented into pharmaceutical & biotechnology companies, hospital, research & academic laboratories, and others.
Detailed Regional Analysis
The Americas region leads the market for monoclonal antibody custom service due to the presence of a large base of the patient population, well-developed technology, increased healthcare expenditure and the existence of the top contenders in the market. The European region occupies the next position in the monoclonal antibody custom service market. It is anticipated that the backup provided by the government bodies for research & development is fuelling the market in the European region. The Asia Pacific region is projected to surge rapidly during the forecast period. The high growth rate is owing to rising risk of infectious diseases in this region. The Middle East and Africa region controls the least portion of the market due to the existence of slow developing and economically backward countries, particularly, in the African region.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4515
TABLE OF CONTENTS
1 Report Prologue
2 Introduction
2.1 Scope Of Study 15
2.2 Research Objective 15
2.3 Assumptions & Limitations 15
2.3.1 Assumptions 15
2.3.2 Limitations 15
2.4 Market Structure 16
3 Research Methodology
3.1 Primary Research 18
3.2 Secondary Research 18
3.3 Market Size Estimation 18
3.3.1 Market Share Analysis 19
3.4 Market Pricing Approach 20
4 Market Dynamics
4.1 Introduction 21
4.2 Drivers 22
4.2.1 Increasing Investment In Research & Development (Weightage 45%) 22
4.2.2 Increasing Prevalence Of Chronic Diseases And Infection (Weightage 40%) 23
4.2.3 Increasing Prevalence Of Immunological Diseases (Weightage 15%) 24
Global Competitive Analysis
The opportunities for growth and innovation have increased at a rapid pace transforming the landscape of the market. The competitors in the market have been spurred to devise strategic road-maps that capitalize on the positive market cues. Engaging and converting prospective opportunities is modifying the growth pace of the market considerably. The momentum of the market's growth has altered the competitive background of the market. The vital trends and players have established a positive tone for development. By guaranteeing demand and supply are in balance the competitors can unlock new opportunities for growth. The key players and trends have created a positive tone for development.
GenScript, Thermo Fisher Scientific, Creative-Biolabs, Abnova Corporation, ProMab Biotechnologies Inc, Abcam plc, Envigo, and others are the significant contenders shaping the growth of the market in the forecast period.
Industry Updates:
Immunoprecise Antibodies has announced of late that it has signed a binding letter of intent with U-Protein Express BV. The Company has approved to acquire all of the outstanding and issued shares of U-Protein. This denotes a key step in the board of directors' constant review of potential strategic acquisition opportunities for the Company. This transformative acquisition is an outstanding strategic fit for ImmunoPrecise as it is corresponding to our expertise in custom monoclonal antibody production as well as offering an exceptional opportunity to grow their business into the European marketplace.
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4515
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.